Respiratory Failure clinical trials at UCLA
2 in progress, 1 open to eligible people
Revefenacin in Acute Respiratory Insufficiency in COPD
open to eligible people ages 40 years and up
RARICO is a pragmatic, randomized, controlled, double-blinded, multi-center trial evaluating the safety and feasibility of nebulized revefenacin in comparison to nebulized ipratropium in patients with COPD and acute respiratory failure requiring invasive mechanical ventilation.
Los Angeles, California and other locations
Precision Ventilation vs Standard Care for Acute Respiratory Distress Syndrome
Sorry, not currently recruiting here
The goal of this interventional study is to compare standard mechanical ventilation to a lung-stress oriented ventilation strategy in patients with Acute Respiratory Distress Syndrome (ARDS). Participants will be ventilated according to one of two different strategies. The main question the study hopes to answer is whether the personalized ventilation strategy helps improve survival.
Los Angeles, California and other locations
Our lead scientists for Respiratory Failure research studies include Igor Barjaktarevic, MD, PhD Steven Y. Chang, MD, PhD.
Last updated: